Susquehanna International Group’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
Other funds holding SANA
FP
VCM
MG
IHAM
Susquehanna International Group's SANA Position: Q1 2026 in Review
Susquehanna International Group reduced its Sana Biotechnology (SANA) stake by 25% in Q1 2026, selling an estimated $544K and leaving 421,555 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #7391.
Susquehanna International Group first reported a position in SANA in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.28M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.
- Susquehanna International Group held 421,555 shares of Sana Biotechnology worth $1.21M as of Q1 2026.
- Susquehanna International Group sold 138,195 Sana Biotechnology shares in Q1 2026, an estimated $544K.
- Sana Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7391 holding.
- Susquehanna International Group first reported a position in Sana Biotechnology in Q2 2021 and has held it in 20 quarters since.
- Susquehanna International Group's Sana Biotechnology position peaked at $2.28M in Q4 2025.
- 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.